NIH Office of Science Policy,
National Institutes of Health (NIH),
The Novel and Exceptional Technology and Research Advisory Committee is a federal advisory committee that provides recommendations to the NIH Director and a public forum for the discussion of the scientific, safety, and ethical issues associated with emerging biotechnologies.
NExTRAC proceedings and reports are posted to the Office of Science Policy’s Web site to enhance their accessibility to the scientific and lay public.
NExTRAC provides advice to the Director of the National Institutes of Health (NIH) on matters related to the conduct and oversight of research involving emerging technologies in biomedical science. NExTRAC also makes recommendations on research involving the use of, and developments in, emerging biotechnologies and will address scientific, safety, ethical, and social issues associated with areas of emerging biotechnology research for which the NIH requests advice or guidance.
One of the technologies this committee is considering is gene drive.
The November 2020 meeting was a workshop: GENE DRIVES: BIOSAFETY GUIDANCE AND CONDITIONS FOR FIELD RELEASE RESEARCH
More related to this:
https://www.geneconvenevi.org/wp-content/uploads/2020/11/NIH.png 300 300 David Obrochta /wp-content/uploads/2019/10/GC-color-logo-for-header-3277-x-827-1030x260.png David Obrochta2020-11-09 19:56:252020-11-09 20:29:27Novel and Exceptional Technology and Research Advisory Committee – NExTRAC -NIH